Intelligent Pain Management System with Preservative-Free Intranasal Composition

The invention integrates a preservative-free intranasal composition with advanced technologies such as AI, IoT, and blockchain to create a personalized, data-driven pain management system for treating various pain conditions.

The original patent disclosed a preservative-free intranasal composition for treating pain associated with tri-geminal neuralgia, facial neuropathic pain, facial cancer induced neuropathic pain, migraine pain, and cluster headache pain. However, the original composition lacked real-time monitoring and personalized dosing capabilities, which limited its effectiveness. The new inventive concept addresses these limitations by incorporating advanced technologies to provide a more efficient and effective pain management system.

The system consists of a preservative-free intranasal composition dispenser, an AI-powered pain monitoring system, and a communication module for transmitting patient data to a healthcare provider. The dispenser is actuated by a mechanical pump metered dose spray device and is integrated with a wearable IoT device that provides real-time feedback on optimal dosing and administration techniques. The system utilizes a blockchain-based tracking mechanism to monitor patient adherence to the pain treatment regimen. The AI-powered pain monitoring system analyzes data from the wearable IoT device and identifies optimal dosing regimens and administration techniques, transmitting the optimized treatment plan to a healthcare provider via a blockchain-based communication network.

The new claims introduce the integration of advanced technologies such as AI, IoT, and blockchain with the preservative-free intranasal composition, providing a novel and non-obvious solution for personalized pain management. The inventive step lies in the synergistic combination of these technologies to create a more efficient and effective pain management system.

Alternative embodiments of the inventive concept could include integrating the preservative-free intranasal composition with other advanced technologies such as virtual or augmented reality, or using different types of dispensers or administration devices. Variations of the system could include using different AI algorithms or blockchain platforms, or incorporating additional sensors or monitoring systems.

The intelligent pain management system has significant commercial potential in the pharmaceutical and healthcare industries, particularly in the treatment of chronic pain conditions. The system's ability to provide personalized, data-driven pain management solutions could lead to improved patient outcomes and reduced healthcare costs.